Live map depicts spread of coronavirus

Conflict deepens health crisis across Middle East, WHO says March 11, 2026
More than ten days into the latest escalation of conflict in the Middle East, health systems across the Region are coming under strain as injuries and displacement rise, attacks on health care continue, and public health risks increase.National health authorities in Iran report more than 1300 deaths and 9000 injuries, and in Lebanon report at […]
Chile becomes the first country in the Americas to be verified by WHO for the elimination of leprosy March 4, 2026
The World Health Organization (WHO), together with the Pan American Health Organization (PAHO), congratulates Chile for becoming the first country in the Americas – and the second globally – to be officially verified as having eliminated leprosy disease.
Recommendations for influenza vaccine composition for the 2026-2027 northern hemisphere season February 27, 2026
The World Health Organization (WHO) today announced recommendations for the viral composition of influenza (or “flu”) vaccines for the 2026-2027 northern hemisphere influenza season. The announcement was made following a 4-day consultation examining global influenza surveillance data.

Multi-country foodborne event caused by cereulide in infant formula products February 19, 2026
From 19 December 2025 to 13 February 2026, six EU countries and the United Kingdom reported infants with gastrointestinal symptoms following the consumption of contaminated infant formula.
Threat Assessment Brief: Assessing the risk of influenza for the EU/EEA in the context of increasing circulation of A(H3N2) subclade K November 20, 2025
Circulating respiratory viruses, including influenza viruses, SARS-CoV-2 and RSV, all contribute to pressure on healthcare systems during winter in the EU/EEA.
Prolonged multi-country outbreak of Salmonella Strathcona ST2559 linked to consumption of tomatoes in the European Union/European Economic Area – first update October 23, 2025
A prolonged cross-border outbreak of Salmonella Strathcona ST2559 is ongoing in the European Union/European Economic Area (EU/EEA). From 2023 to 30 September 2025, 437 confirmed cases of S. Strathcona ST2559 were identified in 17 EU/EEA countries (205 additional cases since the first rapid outbreak assessment published on 12 November 2024).